Sartorius, DE0007165631

Sartorius stock draws support at EUR 258.65 despite minus 0.65 percent

Published on 09/30/2026 at 14:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sartorius stock stood at EUR 258.65 with minus 0.65 percent on September 30, 2026. Barclays raised its target to EUR 300.00 as H1 sales rose 7.7 percent.

Fotorealistische Bioreaktor-Anlage in Reinraumhalle mit Edelstahltanks und Technikern
Sartorius AG (Vz.) DE0006292006 zeigt fotorealistisch eine sterile Bioreaktor-Anlage mit Technikern in weißer Reinraum-Schutzkleidung, Illustration mit AI erstellt.

Sartorius stock (ISIN DE0007165631) was trading at EUR 258.65 at Lang & Schwarz on September 30, 2026 at 2:11 p.m. CEST, with minus 0.65 percent versus the prior close of EUR 260.35. The share price is being measured against a dense run of analyst updates before the third-quarter report scheduled for October 22, 2026. dpa-AFX reported that JPMorgan kept its Overweight rating and EUR 295.00 target after an analyst update dated September 27, 2026.

Analysts lift their targets

dpa-AFX reported on September 7, 2026 that Barclays raised its Sartorius price target from EUR 260.00 to EUR 300.00 and retained an Overweight rating. The new target lies 15.99 percent above the Lang & Schwarz price.

dpa-AFX reported on September 10, 2026 that Berenberg lifted its target from EUR 270.00 to EUR 280.00 and maintained a Buy rating. The sequence gives the stock a clear earnings-related checkpoint rather than a purely technical story.

H1 growth meets a firm outlook

For the first six months of 2026, group sales revenue increased 7.7 percent in constant currencies, while underlying EBITDA rose 3.9 percent to EUR 548.00 million and the underlying EBITDA margin reached 30.3 percent, according to the Yahoo Finance transcript of the H1 2026 earnings call.

The same transcript says management confirmed full-year 2026 constant-currency sales growth of 5 percent to 9 percent and an underlying EBITDA margin slightly above 30 percent. JPMorgan's September 27, 2026 note also points to the October 22, 2026 third-quarter report as the next major test for expectations.

Stock stays below EUR 260

Sartorius stock was trading at EUR 258.65 at Lang & Schwarz on September 30, 2026 at 2:11 p.m. CEST, with minus 0.65 percent versus the prior close of EUR 260.35. The market is weighing the H1 operating numbers against the targets that analysts have set ahead of the October report.

Sartorius stock facts

  • Company: Sartorius AG
  • ISIN: DE0007165631
  • WKN: 716563
  • Ticker: SRT3
  • Primary exchange: Xetra
  • Price Lang & Schwarz (as of September 30, 2026, 2:11 p.m. CEST): EUR 258.65
  • Change versus prior close: minus 0.65 percent
  • Prior close Lang & Schwarz (September 29, 2026): EUR 260.35
  • Sector / Industry: Healthcare / Medical Instruments & Supplies
  • Index membership: MDAX and TecDAX
  • Next earnings date: October 22, 2026

More news and analyses on Sartorius stock

Disclaimer...

en | DE0007165631 | SARTORIUS | boerse | 70204325 | bgmi